title: Eupatilin Inhibits Gastric Cancer Cell Growth by Blocking STAT3-Mediated VEGF Expression.
abstract: OBJECTIVE
  Eupatilin is an antioxidative flavone and a phytopharmaceutical derived from Artemisia asiatica. It has been reported to possess anti-tumor activity in some types of cancer including gastric cancer. Eupatilin may modulate the angiogenesis pathway which is part of anti-inflammatory effect demonstrated in gastric mucosal injury models. Here we investigated the anti-tumor effects of eupatilin on gastric cancer cells and elucidated the potential underlying mechanism whereby eupatilin suppresses angiogenesis and tumor growth.
  
  
  METHODS
  The impact of eupatilin on the expression of angiogenesis pathway proteins was assessed using western blots in MKN45 cells. Using a chromatin immunoprecipitation assay, we tested whether eupatilin affects the recruitment of signal transducer and activator of transcription 3 (STAT3), aryl hydrocarbon receptor nuclear translocator (ARNT) and hypoxia-inducible factor-1α (HIF-1α) to the human VEGF promoter. To investigate the effect of eupatilin on vasculogenesis, tube formation assays were conducted using human umbilical vein endothelial cells (HUVECs). The effect of eupatilin on tumor suppression in mouse xenografts was assessed.
  
  
  RESULTS
  Eupatilin significantly reduced VEGF, ARNT and STAT3 expression prominently under hypoxic conditions. The recruitment of STAT3, ARNT and HIF-1α to the VEGF promoter was inhibited by eupatilin treatment. HUVECs produced much foreshortened and severely broken tubes with eupatilin treatment. In addition, eupatilin effectively reduced tumor growth in a mouse xenograft model.
  
  
  CONCLUSIONS
  Our results indicate that eupatilin inhibits angiogenesis in gastric cancer cells by blocking STAT3 and VEGF expression, suggesting its therapeutic potential in the treatment of gastric cancer.
authors.affiliation: Department of Surgery, Yonsei University College of Medicine, Seoul, Korea.
authors.forename: Jae-Ho
authors.initials: JH
authors.lastname: Cheong
authors.forename: Sung Yi
authors.initials: SY
authors.lastname: Hong
authors.forename: Yanjun
authors.initials: Y
authors.lastname: Zheng
authors.forename: Sung Hoon
authors.initials: SH
authors.lastname: Noh
references.citation: J Investig Dermatol Symp Proc. 2000 Dec;5(1):24-33
references.pmid: 11147671
references.citation: Oncogene. 2000 May 15;19(21):2474-88
references.pmid: 10851046
references.citation: Oncogene. 2005 Aug 25;24(36):5552-60
references.pmid: 16007214
references.citation: Cancer Res. 1999 Apr 1;59(7):1592-8
references.pmid: 10197634
references.citation: Oncogene. 2002 Mar 27;21(13):2000-8
references.pmid: 11960372
references.citation: Nature. 1994 Feb 10;367(6463):576-9
references.pmid: 8107827
references.citation: Oncogene. 2000 Nov 16;19(48):5419-27
references.pmid: 11114718
references.citation: N Engl J Med. 1995 Dec 28;333(26):1757-63
references.pmid: 7491141
references.citation: Annu Rev Cell Dev Biol. 1999;15:551-78
references.pmid: 10611972
references.citation: Trends Mol Med. 2001 Aug;7(8):345-50
references.pmid: 11516994
references.citation: Proc Natl Acad Sci U S A. 2000 Feb 15;97(4):1749-53
references.pmid: 10677529
references.citation: Oncogene. 2005 Apr 28;24(19):3110-20
references.pmid: 15735682
references.citation: Cancer Lett. 2007 Jun 28;251(2):199-210
references.pmid: 17129668
references.citation: Science. 1997 Sep 12;277(5332):1630-5
references.pmid: 9287210
references.citation: Proc Natl Acad Sci U S A. 1995 Jun 6;92(12):5510-4
references.pmid: 7539918
references.citation: Gut. 2001 Sep;49(3):364-71
references.pmid: 11511558
references.citation: N Engl J Med. 1971 Nov 18;285(21):1182-6
references.pmid: 4938153
references.citation: Nature. 1992 Oct 29;359(6398):843-5
references.pmid: 1279431
references.citation: Curr Opin Oncol. 1999 Nov;11(6):490-6
references.pmid: 10550013
references.citation: Cancer Res. 1999 Aug 15;59(16):3915-8
references.pmid: 10463582
references.citation: Free Radic Biol Med. 2001 Apr 15;30(8):905-15
references.pmid: 11295533
references.citation: Clin Cancer Res. 1999 Aug;5(8):2164-70
references.pmid: 10473101
references.citation: Arch Pharm Res. 1997 Oct;20(5):414-9
references.pmid: 18982482
references.citation: J Biol Chem. 1998 Jan 9;273(2):1052-7
references.pmid: 9422768
references.citation: Cancer Res. 2000 Nov 1;60(21):6189-95
references.pmid: 11085544